KPTI
KARYOPHARM THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
KARYOPHARM THERAPEUTICS INC (KPTI) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$7.48M; the largest are Izzy Englander, Davidson Kempner, Renaissance Technologies. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 1 trimmed. 1 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Common-stock holders42 also report options
Congress trades1
Price$1.21vs quarter-end-87.67%
Sectors0
This quarter's moves
Top holderNew1
Added1
Trimmed / sold1
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Davidson KempnerHold
Value $2.93M0.1% of portfolio300,0002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Davidson Kempner | $2.93M | 0.1% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $510.0K— of portfolio52,2002026 Q2
Value $351.7K— of portfolio36,0002026 Q2
Value $133.8K— of portfolio13,7002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $510.0K | — | — |
| Izzy EnglanderPUT | $351.7K | — | — |
| Ken GriffinPUT | $133.8K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.